En AndalucÃa, it is estimated that 30% of patients with Alzheimer’s disease is still undiagnosed.
– under the motto each diagnosis, a person ” is held tomorrow the day world the Alzheimer’s, a degenerative brain disease that affects a 4.2 to 6% of the Spanish population over 65
-the Andalusian society of Neurology recommend which the health system have greater resources the Neurology services dementia units, to improve the early diagnosis of these patients and the quality of its healthcare ”
Seville, 2011-September 21 September is celebrated under the motto each diagnosis, a person ” the day world the Alzheimer’s, a degenerative brain disease characterized by deterioration of intellectual or cognitive functions of slow courseprogressive and multifactorial cause. According to recent studies, affected a 4.2 to 6% of the Spanish population was 65 years of age or older. In Andalusia, however, the number of people suffering from this disease is more complex to define, because says doctor Félix Viñuela, neurologist of the Andalusian society of Neurology (SAN), it is estimated that there are still 30% of patients without definite diagnosis, which becomes a challenge to be solved ”.
The neurologist in the Saint warns that in our community is Miss greater institutional support to clinical research in Alzheimer’s disease. These resources, however, would not only be pioneers in r & d at the national level, and even international, but it would have a very positive direct impact on the quality of care and it would be a generator of wealth and value added in Andalusia ”.
Therefore, the doctor Viñuela points out that would be advisable that the sanitary system face increased resources to the Neurology services dementia units, to improve the quality of health care ”.
Latest news and treatments
On the latest developments, the neurologist suggests that have been published the new criteria for clinical diagnosis of dementia alzheimer type, revising the earlier dating of 27 years ago. These include new complementary diagnostic techniques that allow the realization of early diagnosis more accurately ”.
In addition, the specialist refers to the treatment for this disease. must emphasize the importance of progress in these treatments, since this disease is closely related to age. The population aging of Western countries is that it is becoming a priority its detection and early treatment, to get the delay of the natural course of the disease. It is estimated that an intervention which delay the disease five years, would reduce the number of patients with Alzheimer’s disease in more than half ”
Next annual meeting of the SAN
Alzheimer’s disease and other neurological diseases such as headache, multiple sclerosisParkinson’s disease, epilepsy, Huntington’s disease or the treatment of the stroke will be discussed at the 34TH annual meeting of the SAN, which will be held from 13 to 15 October in the Palacio de Congresos of Cadiz and it will be chaired by Dr. Santiago Cousido (director of the unity of management clinic of neuroscience of the Hospital Universitario Puerta del Mar)(, Cádiz).
